FLSM

Frazier Life Sciences Management Portfolio holdings

AUM $3.34B
1-Year Est. Return 92.56%
This Quarter Est. Return
1 Year Est. Return
+92.56%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.14B
AUM Growth
-$232M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
57
New
Increased
Reduced
Closed

Top Buys

1
+$43.7M
2
+$38.3M
3
+$31.7M
4
RARE icon
Ultragenyx Pharmaceutical
RARE
+$17.5M
5
SVRA icon
Savara
SVRA
+$16.8M

Top Sells

1
+$124M
2
+$52M
3
+$35.6M
4
GPCR icon
Structure Therapeutics
GPCR
+$27M
5
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
+$22.9M

Sector Composition

1 Healthcare 99.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$22M 1.03%
7,381,090
27
$21.8M 1.02%
1,148,591
28
$17.5M 0.82%
+425,000
29
$16.1M 0.75%
4,623,324
30
$16.1M 0.75%
393,000
31
$15.8M 0.74%
+4,401,371
32
$13.4M 0.63%
+1,152,456
33
$13.3M 0.62%
832,220
34
$12.8M 0.6%
3,010,727
+539,023
35
$10.7M 0.5%
2,286,135
+333,278
36
$9.98M 0.47%
3,062,558
+246,264
37
$8.01M 0.37%
1,000,000
38
$7.99M 0.37%
+2,958,579
39
$7.9M 0.37%
936,576
40
$7.64M 0.36%
470,338
41
$7.6M 0.36%
285,331
42
$7.34M 0.34%
1,069,244
43
$6.68M 0.31%
2,867,750
44
$4.49M 0.21%
2,088,889
+700,000
45
$4.36M 0.2%
500,333
46
$4M 0.19%
+1,195,179
47
$3.69M 0.17%
+108,762
48
$1M 0.05%
245,692
-33,333
49
$291K 0.01%
264,377
50
– –
-1,030,878
1
2
3